Anti-CD22 scFv h(CD28-FcεRIγ) CART, pCDCAR1
- 1.00 Dollar US$
- Published date: February 8, 2018
-
- Shirley, New York, United States
https://www.creative-biolabs.com/car-t/pcdcar1-cd22-h-28γ-t-100.htm The vector of anti-CD22 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD22. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-CD22 antibody linked to CD28 transmembrane domain/ endodomain and FcεRIγ signaling domains. And the vector product was designed for the treatment of acute lymphoblastic leukemia (ALL) .










Useful information
- Avoid scams by acting locally or paying with PayPal
- Never pay with Western Union, Moneygram or other anonymous payment services
- Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
- This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"
Related listings
-
Anti-CD22 scFv h(CD3ζ) CART, pCDCAR1
Drug Development Shirley (New York) February 8, 2018 1.00 Dollar US$https://www.creative-biolabs.com/car-t/pcdcar1-cd22-h-ζ-t-99.htm The vector of anti-CD22 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD22. The T cells are genetically modified through transduction wit...
-
Anti-PD-1 scFv h(CD28-OX40-CD3ζ) CART, pCDCAR1
Drug Development Shirley (New York) February 8, 2018 1.00 Dollar US$https://www.creative-biolabs.com/car-t/pcdcar1-pd-1-h-28oxζ-t-478.htm The vector of anti-PD-1 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human PD-1. The T cells are genetically modified through transductio...
-
Anti-PD-1 scFv h(CD28-41BB-CD3ζ) CART, pCDCAR1
Drug Development Shirley (New York) February 8, 2018 1.00 Dollar US$https://www.creative-biolabs.com/car-t/pcdcar1-pd-1-h-28bbζ-t-477.htm The vector of anti-PD-1 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human PD-1. The T cells are genetically modified through transductio...